Management of small renal masses--update 2011
- PMID: 21776295
- PMCID: PMC3124269
Management of small renal masses--update 2011
Retraction in
-
Retractions.J Med Life. 2012 Jun 12;5(2):246-7. Epub 2012 Jun 18. J Med Life. 2012. PMID: 22802902 Free PMC article. No abstract available.
Abstract
Rationale: The management of renal parenchymal tumors has known many changes over time, a trend that continues today, as a result of technological advances, clinical research and improved diagnostic and therapeutic tools. Unfortunately, conventional cancer treatments--chemotherapy and radiotherapy have proven ineffective and modern approaches such as immunotherapy, angiogenesis inhibitors, though they enjoyed an initial enthusiasm, subsequent studies have shown limited and controversial effects. Thus, surgery remains the gold standard therapy for this type of cancer. The options for the treatment of RCC are numerous, with options that have advantages and disadvantages, with oncological results, in most cases, positive at five years and with different impact on cancer specific survival. It is difficult to compare the results, as these are different techniques with various instruments and intraoperative steps, with more questionable inclusion criteria, selection biases and prosecution, with a tendency for preferential enrollment, different reasons to why randomized prospective studies have not been performed until today.
Objective: This article is a review of the diagnosis and methods of treatment of small renal masses 2011.
Conclusion: At the beginning of the new millennium, kidney cancer, with all the arsenal of techniques and methods of ablative surgery, remains a potentially fatal disease for a high percentage of patients, and the decision to choose a treatment or another should be taken with responsibility, depending on currently existing medical records, the degree of expertise and not based on subjective or other non-standard parameters.
Keywords: active surveillance; computed tomography; nephron sparing surgery; radical nephrectomy; renal cancer.
Figures




Similar articles
-
Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.World J Surg Oncol. 2018 Feb 20;16(1):35. doi: 10.1186/s12957-018-1338-1. World J Surg Oncol. 2018. PMID: 29463251 Free PMC article.
-
Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively-maintained database.Int J Urol. 2019 Apr;26(4):465-474. doi: 10.1111/iju.13909. Epub 2019 Feb 28. Int J Urol. 2019. PMID: 30818418
-
[Nephron-sparing surgery 2012].Aktuelle Urol. 2012 Dec;43(6):399-402. doi: 10.1055/s-0032-1330002. Epub 2012 Nov 29. Aktuelle Urol. 2012. PMID: 23196778 Review. German.
-
Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney.J Urol. 2002 Oct;168(4 Pt 1):1356-9; discussion 1359-60. doi: 10.1016/S0022-5347(05)64448-5. J Urol. 2002. PMID: 12352392
-
[Standard surgery for small renal masses (<4 cm)].Urologe A. 2018 Mar;57(3):280-284. doi: 10.1007/s00120-018-0583-9. Urologe A. 2018. PMID: 29468282 Review. German.
References
-
- Mortensen H. Transthoracic nephrectomy . J Urol . 1948;60:855–858. - PubMed
-
- Robson CJ. Radical nephrectomy for renal cell carcinoma . J Urol . 1963;89:37. - PubMed
-
- Robson CJ, Churchill BM. The results of radical nephrectomy for renal cell carcinoma . Trans Am Assoc Genitourin Surg . 1968;60:122. - PubMed
-
- Hollenbeck BK. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? . Urology. 2006;67(2):254–859. - PubMed
-
- Frank I. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma . J Urol . 2003;170:2225–2232. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical